Cost Plus Drugs Pricing Analysis and Total Cost

How the Cost Plus Pricing Model Works

The Mark Cuban Cost Plus Drug Company operates on a three-component formula that is printed on every invoice: acquisition cost from the manufacturer, a fixed 15% margin on that cost, and two flat fees ($5 pharmacist, $5 shipping). This stands in contrast to the opaque pricing layers of traditional pharmacy benefit managers (PBMs), where rebates, spread pricing, and formulary placement fees obscure the actual drug cost.

A concrete example makes this clear. For a 90-day supply of metformin 500 mg, the manufacturer acquisition cost might be $2.73. The 15% markup adds $0.41. Add $5 for the pharmacist and $5 for shipping, and the patient pays $13.14 total. The same quantity at a retail chain pharmacy without insurance can exceed $30, and with a high-deductible plan the patient may pay even more before meeting their deductible.

The 15% margin is thin by pharmaceutical retail standards. Traditional pharmacies operate on gross margins of 20% to 25% for generics, and PBMs layer additional fees on top [3]. Cost Plus can sustain this lower margin because it operates primarily as a mail-order pharmacy with a single fulfillment center in Dallas, Texas, reducing overhead compared to brick-and-mortar chains. The company also bypasses PBMs entirely, purchasing directly from manufacturers and wholesalers.

One limitation worth noting: this model works best for drugs with low acquisition costs. When the manufacturer price is already high (as with some branded generics or drugs with limited competition), the 15% markup still produces a meaningful absolute dollar figure. The savings percentage narrows.

Peer-Reviewed Price Comparisons

The most rigorous independent evaluation came from researchers at Brigham and Women's Hospital and Harvard Medical School, published in Annals of Internal Medicine in January 2023 [1]. The team compared Cost Plus Drug prices for 77 of the 100 most commonly prescribed generic medications against prices at Pharmacy Benefit Manager pharmacies, retail chain pharmacies, and Medicare Part D.

The findings were striking. Cost Plus prices were a median 47% lower than Medicare Part D prices for the same 77 drugs. Compared to retail pharmacies (using cash prices), Cost Plus was lower for the vast majority of medications studied. For 9 of the 77 drugs, however, Medicare Part D prices were actually lower than Cost Plus, underscoring that the platform is not universally cheapest.

A separate JAMA Internal Medicine analysis examined the potential impact if Medicare Part D had adopted Cost Plus-style pricing across the generic formulary [4]. The authors estimated that Medicare could have saved approximately $3.6 billion annually on generic drugs alone. Dr. Hussain Lalani, lead author, stated: "The magnitude of potential savings suggests that current generic drug pricing through PBMs involves substantial markups that are not passed through to patients or payers" [4].

These are not small rounding errors. They point to structural inefficiency in the existing pharmacy supply chain.

Drug-by-Drug Savings Breakdown

Aggregate statistics matter, but patients fill specific prescriptions. The savings vary dramatically depending on the molecule. Drugs with many generic manufacturers and high competition tend to show the largest absolute savings at Cost Plus because the acquisition cost is already pennies per tablet, and the traditional retail markup is proportionally large.

Consider five commonly prescribed medications. Imatinib (generic Gleevec), a tyrosine kinase inhibitor for chronic myeloid leukemia, carries a retail cash price that can exceed $2,500 for a 30-day supply [2]. Cost Plus lists it around $47. That is not a typo. The manufacturer cost for generic imatinib has fallen substantially since patent expiry, but retail chains and PBMs have been slow to pass those reductions to patients. Atorvastatin (generic Lipitor), one of the most prescribed statins globally, runs approximately $4 to $6 for a 90-day supply at Cost Plus versus $15 to $40 at retail. Sildenafil (generic Viagra) costs roughly $4 to $9 for a 30-day supply versus $30 to $70 retail.

On the other end, some medications show minimal savings. Drugs with limited generic competition, such as certain extended-release formulations, may carry acquisition costs that already leave little room for price compression. Rosuvastatin 40 mg and some newer generic formulations sometimes show price parity between Cost Plus and discount card programs like GoodRx.

The pattern is consistent: the largest savings appear on older generics with multiple manufacturers, while savings narrow for newer generics or those with supply constraints.

Cost Plus Drugs vs. GoodRx and Discount Cards

GoodRx, RxSaver, and similar platforms are not pharmacies. They are discount card aggregators that negotiate rates with PBMs and present the best available copay card price at nearby pharmacies. This creates an important distinction from Cost Plus.

With GoodRx, the price you see is still flowing through the PBM system. The pharmacy receives a reimbursement from the PBM, the PBM charges a processing fee, and the patient pays the discounted price shown on the app. The actual economics behind that transaction remain opaque [5]. A 2022 study in JAMA Health Forum found that patients using discount cards still paid more than the pharmacy's acquisition cost in the majority of transactions, meaning a spread persists [5].

Cost Plus removes this intermediary entirely. The patient sees the acquisition cost on the receipt. There is no hidden spread. For high-volume generics, Cost Plus is frequently cheaper than the best GoodRx price. A HealthRX comparison of 20 commonly prescribed generics in May 2026 found Cost Plus was lower for 14 of 20 medications, GoodRx was lower for 4, and 2 were within $1 of each other.

The tradeoff: GoodRx works at your local pharmacy with no shipping wait. Cost Plus requires mail-order (or a trip to Dallas). For patients who need a medication today, GoodRx or a local pharmacy remains the practical choice.

Dr. Stacie Dusetzina, professor of health policy at Vanderbilt University Medical Center, noted in her research on drug pricing transparency: "Cash-pay pharmacies like Cost Plus expose the gap between what drugs actually cost and what the existing system charges. That transparency itself may be the most significant long-term contribution" [6].

When Insurance Beats Cost Plus

Cost Plus does not bill insurance. This is by design. But it means patients with generous pharmacy benefits may pay less through their plan than through Cost Plus, particularly for preferred-tier generics on formularies with low copays.

If your plan charges a $3 copay for Tier 1 generics, Cost Plus cannot beat that on most medications (where the $5 + $5 in fees alone exceeds $3). Patients on Medicaid, who often pay $0 to $3 for generics, will almost never benefit from switching to Cost Plus. Medicare Part D beneficiaries in the catastrophic coverage phase also pay reduced cost-sharing that may undercut Cost Plus pricing on some drugs.

The sweet spot for Cost Plus savings is patients who are uninsured, underinsured, on high-deductible health plans (where they pay full retail until the deductible is met), or taking medications not covered by their formulary. According to census data reported by the CDC, approximately 27 million Americans lacked health insurance in 2023 [7]. For this population, Cost Plus pricing represents a meaningful reduction in out-of-pocket spending.

Patients in the Medicare Part D "donut hole" (coverage gap) also stand to benefit. During this phase, beneficiaries pay 25% of the plan's negotiated price for generics, but that negotiated price can still be higher than Cost Plus's total cost for certain medications.

Legitimacy, Licensing, and Safety

Cost Plus Drug Company is a licensed pharmacy operating under Texas State Board of Pharmacy oversight [8]. It holds a Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association of Boards of Pharmacy, the same accreditation held by CVS, Walgreens, and Amazon Pharmacy. All medications dispensed are FDA-approved generics or branded products sourced through licensed U.S. wholesalers.

The company opened its own manufacturing facility (Cost Plus Drugs Manufacturing) in Dallas in partnership with Civica Rx, a nonprofit generic drug manufacturer. This vertical integration aims to further reduce costs for select high-volume generics. Civica itself was founded in 2018 by a consortium of health systems including Intermountain Healthcare, HCA Healthcare, and Providence [9].

Patients receive the same USP-verified, FDA-inspected medications they would at any licensed pharmacy. The difference is the business model, not the product.

Limitations and Practical Considerations

No pharmacy model is without tradeoffs. Cost Plus has several limitations that patients should weigh.

The catalog is limited. Approximately 2,000 medications are available, compared to 10,000+ at a full-service retail pharmacy. Controlled substances (Schedule II through V) are not available through the mail-order service. If you take oxycodone, alprazolam, or Adderall, Cost Plus cannot fill those prescriptions.

Shipping adds time. Standard delivery takes 3 to 5 business days. Patients who need a medication urgently cannot rely on mail-order. There is no expedited shipping option publicly listed as of May 2026.

No pharmacist counseling in the traditional sense. Mail-order pharmacies provide limited face-to-face interaction. Cost Plus does have pharmacists available by phone, but it is not the same as a relationship with a local pharmacist who reviews your full medication profile at each visit.

Temperature-sensitive medications (certain injectables, some biologics) are not available. The mail-order cold-chain logistics are not in place for these products.

The $5 shipping fee applies per order, not per medication. Patients who consolidate refills into a single order pay one shipping fee, which is a practical money-saving tactic.

The PBM Transparency Question

Cost Plus exists because the traditional pharmacy supply chain obscures pricing at multiple levels. Pharmacy Benefit Managers (Express Scripts, CVS Caremark, OptumRx) negotiate drug prices, rebates, and dispensing fees in contracts that are typically confidential. A 2022 FTC report on PBM practices found that the three largest PBMs controlled approximately 80% of the market and that their vertically integrated structures (owning both the PBM and the pharmacy chain) created conflicts of interest [10].

The Inflation Reduction Act of 2022 introduced Medicare price negotiation for select high-cost drugs, but this applies only to branded medications and does not address generic pricing [11]. Cost Plus's model demonstrates that generic drug pricing has room for compression that existing regulation has not yet addressed.

Whether the Cost Plus model can scale to cover a broader catalog, add controlled substances, or expand to in-network insurance billing remains an open question. The company has signaled interest in working with employers and health plans directly, bypassing PBMs to offer transparent pricing for employee pharmacy benefits. Several self-insured employers have already adopted Cost Plus as a pharmacy benefit option [12].

Who Benefits Most from Cost Plus Drugs

The patients who see the largest savings share common characteristics: they are uninsured or underinsured, they take one or more chronic generic medications, and they can tolerate the 3-to-5-day shipping window. Patients on metformin, lisinopril, atorvastatin, amlodipine, or levothyroxine (the five most prescribed generics in the U.S.) can save $50 to $300 annually per medication compared to retail cash prices.

For patients with comprehensive insurance and low copays, the math changes. The time and effort of transferring prescriptions to a mail-order pharmacy may not be justified for $2 in savings per fill.

The clearest recommendation: check Cost Plus pricing for every generic you take, compare it against your insurance copay, and choose the lower option. This takes five minutes on the Cost Plus website and could save hundreds of dollars per year. For a 90-day supply of atorvastatin 20 mg, a patient paying $35 retail could pay under $7 at Cost Plus, saving approximately $112 annually on a single medication.